La Opala RG (LAOPALA)

FairStock Score: 26/100 — RISKY

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 1/1

Key Financials

Strengths

• Debt/Equity is only 0.01, indicating a virtually debt-free balance sheet
• Promoter holding of 65.84% ensures strong alignment with minority shareholders
• Latest quarter net profit margin of ~28% (₹24 Cr on ₹85 Cr sales) demonstrates significant pricing power
• Dividend yield of 3.63% offers a reasonable income cushion while waiting for growth
• Profit growth of 9.54% despite falling sales shows operational efficiency

Concerns

• Sales growth of -7.45% signals weak demand and potential loss of market relevance
• P/E of 22.19 is expensive for a business with negative topline growth
• ROE of 12.47% is below the 15% threshold typical of high-quality compounders
• FairStock Score of 26/100 and stock near 52-week low indicate elevated risk and bearish sentiment

AI Analysis

As a value investor, I look for businesses selling at a discount to their intrinsic worth. La Opala RG is a curious case. On one hand, it has a pristine balance sheet—debt of just 0.01 times equity—and promoter holding of 65.84% aligns ownership with minority shareholders. The dividend yield of 3.63% is respectable, and the latest quarter's net profit margin of 28% (₹24 Cr profit on ₹85 Cr sales) suggests genuine pricing power. But I must not let a good quarter cloud my judgment. Sales have declined 7.45% over the last year, and that worries me deeply. A shrinking topline in a consumer business often means the brand is losing its pull. The profit growth of 9.54% seems driven by margin expansion, not volume, and that path has limits. At ₹178.95, I am paying 22.19 times earnings and 2.46 times book value of ₹72.83. That is not a margin of safety for a slow grower with negative sales momentum. The PEG ratio of 2.33 confirms I am overpaying for whatever growth exists. Benjamin Graham taught me to buy at a discount with a tangible buffer. The stock sits near its 52-week low of ₹162, but a falling knife is not automatically a bargain. The Piotroski score of 6/9 is mediocre, and the FairStock Score of 26/100 flags risk. With ROE at 12.47%, below my preferred 15%, this business does not clear my quality bar. I would wait—either for a lower price or clear evidence of a sales revival—before deploying capital. For now, it is a decent company, but not a compelling investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer